Cited by 235Neuroendocrine regulation and behaviorAdvanced Drug Delivery SystemsNeuropeptides and Animal Physiology

Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay

Open access
Lee, M R, Scheidweiler, K B, Diao, X X, Akhlaghi, F, Cummins, A, Huestis, M A, Leggio, L, Averbeck, B B·2018·Molecular Psychiatry

Abstract

Oxytocin (OT) is a potential treatment for multiple neuropsychiatric disorders. As OT is a peptide, delivery by the intranasal (IN) route is the preferred method in clinical studies. Although studies have shown increased cerebrospinal fluid (CSF) OT levels following IN administration, this does not unequivocably demonstrate that the peripherally administered OT is entering the CSF. For example, it has been suggested that peripheral delivery of OT could lead to central release of endogenous OT. It is also unknown whether the IN route provides for more efficient entry of the peptide into the CSF compared to the intravenous (IV) route, which requires blood-brain barrier penetration. To address these questions, we developed a sensitive and specific quantitative mass spectrometry assay that distinguishes labeled (d5-deuterated) from endogenous (d0) OT. We administered d5 OT (80 IU) to six nonhuman primates via IN and IV routes as well as IN saline as a control condition. We measured plasma and CSF concentrations of administered and endogenous OT before (t=0) and after (t=10, 20, 30, 45 and 60 min) d5 OT dosing. We demonstrate CSF penetrance of d5, exogenous OT delivered by IN and IV administration. Peripheral administration of d5 OT did not lead to increased d0, endogenous OT in the CSF. This suggests that peripheral administration of OT does not lead to central release of endogenous OT. We also did not find that IN administration offered an advantage compared to IV administration with respect to achieving greater CSF concentrations of OT.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2017.27

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intranasal oxytocin elevates brain-level presence of oxytocin.

    “intranasal oxytocin elevates brain-level presence of oxytocin”
  • Exogenous oxytocin is administered intranasally to humans because this is likely the most efficient route for oxytocin to penetrate the brain and bypass the blood-brain barrier.

    “Exogenously, oxytocin is administered intranasally (IN-OT) to humans given that this is likely the most efficient route for OT to penetrate the brain and bypass the blood–brain barrier (BBB) (Lee et al. 2017).”

    From A precision medicine approach to oxytocin trials (2017) · cites this paper as Lee et al. 2017

  • A mass spectrometry study found a significant cerebrospinal fluid increase in labeled oxytocin solely related to exogenous intranasal oxytocin delivery.

    “Authors found that a significant CSF increase in labeled OT that is solely related to the exogenous IN-OT delivery (Lee et al. 2017).”

    From A precision medicine approach to oxytocin trials (2017) · cites this paper as Lee et al. 2017

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lee, M. R., Scheidweiler, K. B., Diao, X. X., Akhlaghi, F., Cummins, A., Huestis, M. A., Leggio, L., & Averbeck, B. B.
Affiliations
  • National Institutes of Health (US)
  • University of Rhode Island (US)
Corresponding author
Lee, M R
Venue
Molecular Psychiatry
Published
2017-03-14
Volume
23
Issue
1
Pages
115-122
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2724271447
Cited by
235
References
30
Citations by year
2026: 3 · 2025: 13 · 2024: 15 · 2023: 15 · 2022: 16 · 2021: 46 · 2020: 38 · 2019: 34 · 2018: 36 · 2017: 18
FWCI
49.07
Type
journal article
Language
en
Open access
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Journal of Media Literacy Education (submittedVersion, cc-by)
  • Digital Commons - URI (University of Rhode Island) (submittedVersion, cc-by)
Funders
  • National Institutes of Health (UH2TR000963)
  • National Institute of Mental Health (ZIAMH002928)
  • National Center for Advancing Translational Sciences
Topics
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
oxytocin, intranasal administration, intravenous administration, cerebrospinal fluid, CSF penetration, blood-brain barrier, endogenous oxytocin, mass spectrometry assay, rhesus monkeys, non-human primates, peptide delivery
MeSH terms
Correlation of Data, Administration, Intranasal, Animals, Chromatography, High Pressure Liquid, Macaca mulatta, Male, Oxytocin, Time Factors, Area Under Curve, Administration, Intravenous

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review